A previous report showed that the expression level of UDPGP, activities of phosphoglucomutase (PGM) and glycogen synthase were all decreased in tumor tissues, so the defective glycogen synthesis process is unable to compete with glycolysis [53]. The gene discussed is UGP2; the disease is neoplasm.